FdaApplication
NDA 017106
Identifiers
- fda_app_no: NDA017106
Properties
| Property | Value |
|---|---|
| applicant_name | MERIDIAN MEDICAL TECHNOLOGIES LLC |
| application_type | NDA |
| approval_date | 2003-06-19 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ATROPEN | ATROPINE | EQ 0.25MG SULFATE/0.3ML | SOLUTION;INTRAMUSCULAR |
| ATROPEN | ATROPINE | EQ 1MG SULFATE/0.7ML | SOLUTION;INTRAMUSCULAR |
| ATROPEN | ATROPINE | EQ 0.5MG SULFATE/0.7ML | SOLUTION;INTRAMUSCULAR |
| ATROPEN | ATROPINE | EQ 2MG SULFATE/0.7ML | SOLUTION;INTRAMUSCULAR |
4 products